Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 124.50 122.00 127.00 124.50 124.50 124.50 932 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 13.0 -23.1 -8.4 - 192

Amryt Pharma Share Discussion Threads

Showing 4851 to 4871 of 5375 messages
Chat Pages: Latest  203  202  201  200  199  198  197  196  195  194  193  192  Older
DateSubjectAuthorDiscuss
27/8/2019
17:17
I have news for you, digadee. The Aegerion takeover deal HASN'T yet gone through, digadee! I'm hopeful it will (it looks to be a certainty it will), but I never count my chickens until they are hatched. I always accept that nothing in life is ever guaranteed. PS. alphabravo's recent post concerning the American court approval for the takeover made it 99% certain it would happen IMO, digadee. Unlike you (?) I base my opinions on the facts. I also NEVER ramp a share I'm invested in, so I prefer to take a more considered view of the future. I may be bullish on AMYT, but I don't want to be thought of as a RAMPER!
papillon
27/8/2019
16:55
Paps,You also doubted that the deal would go through....
digadee
27/8/2019
16:50
I bought 5000 shares just before close today because I met Lara Cutlar at a recent EB awareness day and she really impressed me.Its really only over .17 pence so I dont think I'm paying too much. Hoping Gene therapy works whether it's be viral or non-viral.
chica1
27/8/2019
16:45
In this post, papillon 5 Aug '19 - 19:44 - 4701 of 4737, I suggested that "Hence it's possible that AMYT could relist as soon the admission document is published in "early August" and before the Aegerion deal is finalised." That's what has happened today, but in late, not early August. I suggested this might happen because this happened with FAST when it acquired AMYT.
papillon
27/8/2019
15:41
The CVR scenario is quite interesting. If i've read it correctly if amryt hits targets for 2022 and 2024.... shareholders will get equivalent of 1 extra share @ £1.28 for every share held.. The CVR Record Date is 20 September 2019.
delta0091
27/8/2019
14:49
Quite right, I wasn't sure so thanks. Looking forward to the broker notes and press.
waterloo01
27/8/2019
14:41
The consolidation was 1 for 6, so 100p now would be 16.66 pre consolidation. Admission document makes interesting reading. There are projections for the acquired business indicating significant net income in 2020 and thereafter. Also some timing for the payments (3 tranches) to old shareholders. Together with the revenue targets for one payment and possible date for approval of AP101. If all works out, shareholders will get current price back in cash plus their share of the upside in a potentially very interesting group. And not that far away. Read the document page 486 in part 3 for projections. Good luck.
sidam
27/8/2019
14:36
Divide the current price by 6
dlm2602
27/8/2019
14:25
Probably being thick here Waterloo but isn't it nearer 18p to 19p?
bermudashorts
27/8/2019
14:14
With the consolidation it's trading at 13p ish (old money) I think
waterloo01
27/8/2019
12:48
The ole pi
barnes4
27/8/2019
12:04
We are back
alphabravo321
25/8/2019
07:44
Recent abstract on efficacy of Lojuxta/Juxtapid Conclusions Treatment with lomitapide in homozygous familial hypercholesterolaemia patients has a beneficial effect with a constant decrease of low-density lipoprotein cholesterol by 57% compared with classical lipid-lowering therapy and by 54% compared with classical lipid-lowering therapy and time-averaged level of low-density lipoprotein cholesterol. Https://journals.sagepub.com/doi/full/10.1177/2047487319870007?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
bermudashorts
25/8/2019
07:21
https://epidermolysisbullosanews.com/2019/08/16/amryt-oleogel-s10-phase-3-trial-design-epidermolysis-bullosa/
alphabravo321
23/8/2019
19:40
Could someone give me a nudge please when we’re up and running again. I think I may kick myself for substantially reducing, hey ho!!
bazworth
23/8/2019
19:06
Many thanks alphabravo. Good spot. Excellent news. Aegerion Creditors Approve Drugmaker’s Chapter 11 Plan Bankrupt pharmaceutical company’s chapter 11 plan hands control of assets to Amryt Pharma By Patrick Fitzgerald Aug. 23, 2019 11:43 am ET Creditors of Aegerion Pharmaceuticals Inc. have approved a bankruptcy plan that hands the cholesterol drugmaker’s business to Dublin-based Amryt Pharma PLC. Creditors voted overwhelmingly to support the drugmaker’s chapter 11 plan >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> Hopefully we'll see the admissions document soon.
papillon
23/8/2019
17:05
Excellent and thanks for posting it. Hopefully we'll hear more next week.
waterloo01
23/8/2019
16:45
https://www.wsj.com/articles/aegerion-creditors-approve-drugmakers-chapter-11-plan-11566575038
alphabravo321
23/8/2019
11:51
The timeline in the initial announcement did have a health warning advising it was indicative only...The former CEO is objecting to being treated as a creditor as he has legal indemnity from Aegerion, as in they pay his legal bills and they are treating this as a debt owed rather than an obligation
alphabravo321
23/8/2019
11:40
hTTps://www.law360.com/bankruptcy/articles/1191638/aegerion-pharma-s-ex-ceo-objects-to-ch-11-plan What does it say, alphabravo? Only you have to register to read the article. I'm beginning to doubt that this Aegerion acquisition will happen. The admissions doc was promised for early August and no sign of it. Also no updates from AMYT. Time will tell.
papillon
23/8/2019
11:35
The link doesn't load, alphabravo.
papillon
Chat Pages: Latest  203  202  201  200  199  198  197  196  195  194  193  192  Older
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200127 10:05:19